Administrative Core
Administrative Core
批准号:
7983570
负责人:
James R. Heath
金额:
$11.61万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-03 至 2015-07-31
关键词:
AddressAnimal ModelAnimalsAreaAtlasesBackBaltimoreBasic ScienceBelgiumBiochemistryBioinformaticsBiologicalBiological AssayBiological MarkersBiological ModelsBiologyBloodBlood ProteinsBrainBrain NeoplasmsCCNE1 geneCancer BiologyCancer CenterCancer ModelCancer PatientCancer cell lineCell Culture TechniquesCell LineCellsChemicalsChinClinicClinicalClinical SciencesClinical ServicesClinical TrialsCollaborationsCollectionCommitCommunitiesComplementComplexComprehensive Cancer CenterComputational TechniqueCore FacilityDNADataData SetDevelopmentDevicesDiagnosisDiagnosticDiscipline of Nuclear MedicineDoctor of PhilosophyEngineeringEnrollmentEnvironmentEnzymesEpigenetic ProcessEvaluationFosteringFoundationsFresh TissueFundingGene MutationGene Transduction AgentGenerationsGenesGeneticGenomicsGlioblastomaGliomaGrantGynecologic OncologyGynecologic Oncology GroupHeterogeneityHome environmentHouse miceHumanHuman ResourcesImageImaging technologyImmune systemImmunologic MonitoringImmunologistImmunologyImmunotherapyIn VitroIndividualInstitutesIonsJonsson Comprehensive Cancer Center of University of California Los AngelesKineticsLabelLaboratoriesLettersLuxembourgMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of ovaryManuscriptsMass Spectrum AnalysisMeasurementMechanicsMedicalMelanoma CellMentorsMetabolicMetabolismMethodologyMicrofluidicsMissionModelingMolecularMolecular AnalysisMolecular BiologyMolecular MedicineMonitorMusNanotechnologyOperating RoomsOperative Surgical ProceduresOrganPathologistPathologyPathway AnalysisPathway interactionsPatientsPharmacodynamicsPharmacologyPhysiciansPopulation HeterogeneityPositron-Emission TomographyPrincipal InvestigatorProcessProdrugsPropertyProteinsProteomicsRNA InterferenceRadiochemistryRegenerative MedicineReproduction sporesResearchResearch PersonnelResistanceResourcesSamplingScientistScreening procedureSerumSignal TransductionSmall Interfering RNASolidSpecific qualifier valueStem Cell ResearchSumSupport SystemSystemSystems BiologyT-LymphocyteTechniquesTechnologyTherapeuticTissue BankingTissue BanksTissue HarvestingTissue MicroarrayTissue SampleTissuesTouch sensationTracerTraining ProgramsTranscriptTransgenic MiceTransgenic OrganismsTranslatingTranslationsTumor Stem CellsTumorigenicityUnited States National Institutes of HealthUrsidae FamilyValidationVisionWorkXenograft Modelanticancer researchbasecancer cellcancer diagnosiscancer genomecancer immunotherapycancer stem cellcancer therapycareer developmentchemical synthesisclinically relevantcommercializationcostdesignexperienceexperimental analysisflexibilitygene therapygene therapy clinical trialhuman subjectimage reconstructionimaging probeimprovedin vivoin vivo Cellular and Molecular Imaging Centersin vivo Modelinnovationinstrumentationmedical specialtiesmeetingsmelanomaminimally invasivemolecular imagingmouse modelnanonanofluidicnanoparticleneuro-oncologynovelnovel therapeuticsoncologyoptical imagingpharmacokinetic modelphysical sciencepre-clinicalprogramsprototyperesistance mechanismsmall hairpin RNAstem cell biologysuccesstargeted deliverytechnology developmenttissue culturetooltumortumor growth
中文摘要
描述了NSBCC管理核心。NSBCC由Jim Heath执导,
迈克·菲尔普斯和勒罗伊·胡德。希思对该中心负全面责任,并具体负责
技术开发组件。胡德博士对生物学的监督负有特殊责任
(and系统生物学)项目组成部分,Phelps博士监督NSBCC的临床翻译
项目NSBCC的每一位领导者都在技术开发、临床应用、
翻译和技术商业化。NSBCC领导人以内部审查为指导
理事会由项目主要调查员和外部咨询委员会组成。的描述
这是指导。个人的科学和人员组成如何
项目提供了一种文化,在这种文化中,各组成部分的总和大于所提供的部分-
包括一个经过验证的愿景,加速技术创新的过程,以临床示范。
与NCI资助的项目建立了重要的合作伙伴关系,包括琼森综合癌症中心,
描述了利用基金会资助的项目和机构,如布罗德研究所,
再生医学,进行了讨论。基金会和其他资源提供的额外资金
NSBCC项目的重要杠杆作用,并大大加快了我们进入诊所的途径。
与营利性公司(Sofie Biosciences、Integrated Diagnostics和Momentum)建立更多合作伙伴关系
生物科学)进行了描述。这些合作伙伴关系如何已经导致商业的例子
NSBCC技术的发展(从现有的CCNE资金)。
英文摘要
The NSBCC administrative Core is described. The NSBCC is Directed by Jim Heath and co-Directed by
Mike Phelps & Leroy Hood. Heath bears overall responsibility for the center, and specific responsibility for
the technology development components. Dr. Hood bears specific responsibility for oversight of the biology
(and systems biology) project components, and Dr. Phelps oversees the clinical translation of NSBCC
projects. Each of the NSBCC leaders has extensive expertise in technology development, clinical
translation, and technology commercialization. The NSBCC Leaders are guided by an Internal Review
Council comprised of the Project Principal Investigators, and by an External Advisory Board. Descriptions of
that guidance are provided. Rationale for how the scientific and personnel composition of the individual
projects provide for a culture in which the sum of the components is greater than the parts is given -
including a proven vision for accelerating the process of technology innovation to clinical demonstration.
Significant partnerships with NCI funded programs, including the Jonsson Comprehensive Cancer Center,
are described. Leverage from foundation funded programs and institutes, such as the Broad Institute for
Regenerative Medicine, are discussed. Additional funding from foundation and other resources provides
significant leverage for the NSBCC projects, and significantly accelerates our pathway into the clinic.
Additional partnerships with for-profit companies (Sofie Biosciences, Integrated Diagnostics, and Momentum
Biosciences) are described. Examples of how these partnerships are already leading to the commercial
development of NSBCC technologies (from existing CCNE funding) are provided.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10526102
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
-
批准号:10708901
-
项目类别:
-
资助金额:$254.9万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
-
批准号:10907268
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
-
批准号:10526101
-
项目类别:
-
资助金额:$270.26万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
-
批准号:10526103
-
项目类别:
-
资助金额:$82.5万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
Administrative Core
-
批准号:10708920
-
项目类别:
-
资助金额:$37.85万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
-
批准号:10708924
-
项目类别:
-
资助金额:$75.24万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
Data-driven Patient-Specific Agent Based Models of Metastatic Melanoma for Immunotherapy Response Prediction
-
批准号:10831325
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2022
-
负责人:James R. Heath
-
依托单位:
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
-
批准号:10297588
-
项目类别:
-
资助金额:$59.56万
-
财政年份:2021
-
负责人:James R. Heath
-
依托单位:
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
-
批准号:10489832
-
项目类别:
-
资助金额:$54.79万
-
财政年份:2021
-
负责人:James R. Heath
-
依托单位:
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
-
批准号:10673935
-
项目类别:
-
资助金额:$52.8万
-
财政年份:2021
-
负责人:James R. Heath
-
依托单位:
Steady states and cellular transitions associated with carcinogenesis and tumorprogression
-
批准号:9618374
-
项目类别:
-
资助金额:$54.35万
-
财政年份:2017
-
负责人:James R. Heath
-
依托单位:
Steady states and cellular transitions associated with carcinogenesis and tumorprogression
-
批准号:10249961
-
项目类别:
-
资助金额:$67.07万
-
财政年份:2017
-
负责人:James R. Heath
-
依托单位:
Steady states and cellular transitions associated with carcinogenesis and tumor progression
-
批准号:9355497
-
项目类别:
-
资助金额:$10.07万
-
财政年份:2017
-
负责人:James R. Heath
-
依托单位:
Nanosystems Biology Cancer Center
-
批准号:9132733
-
项目类别:
-
资助金额:$244.66万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
Crump Preclinical Imaging Core
-
批准号:8962028
-
项目类别:
-
资助金额:$14.21万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
Project 2: Specifically Targeting Oncoproteins with PCC Agent-Loaded Nanoparticles: KRASG12D and AktE17K
-
批准号:8962031
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies
-
批准号:8962032
-
项目类别:
-
资助金额:$63.8万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
Nanosystems Biology Cancer Center
-
批准号:8962026
-
项目类别:
-
资助金额:$232.5万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
Administrative Core
-
批准号:8962034
-
项目类别:
-
资助金额:$11.84万
-
财政年份:2015
-
负责人:James R. Heath
-
依托单位:
海外基金